Sponsors

 LOCAL SPONSORSHIP BENEFITS FOR ISAMVALLETTA 2022 (HYBRID) GLOBAL CONGRESS

 

Interested organizations may opt for the following Package Options:

Package 1

• Acknowledgement in the ISAMValletta 2022 (Hybrid) Global Congress webpages
• Link to sponsor website and information on relevant pages; 4 complimentary full delegate in person registrations for the ISAMValletta 2022 (Hybrid) Global Congress;
• An exhibition table space at the congress venue during in Valletta, Malta during the event.

The above sponsorship benefits are available for Eur 5000 excluding VAT 

Package 2

• Acknowledgement in all ISAMValletta 2022 (Hybrid) Global Congress webpages 
• Link to sponsor website and information on relevant webpages;
• 2 complimentary full delegate in person registrations for the ISAMValletta 2022 (Hybrid) Global Congress;
• Space for a poster (roll-up banner to be provided by sponsor) at the congress venue in Valletta, Malta in corridors, during the event;
• Any promotional material provided by sponsor to be included in the registration package.

The above sponsorship benefits are available for Eur 2000 excluding VAT 

Package 3

• Acknowledgement in all ISAMValletta 2022 (Hybrid) Global Congress webpages 
• Link to sponsor website and information on relevant webpages;
• 2 complimentary full delegate virtual registrations for the ISAMValletta 2022 (Hybrid) Global Congress;
• Space for a poster (roll-up banner to be provided by sponsor) at the congress venue in Valletta, Malta in corridors during the event;
• Any promotional material provided by sponsor to be included in the registration package.

The above sponsorship benefits are available for Eur 500 excluding VAT 

Should you be interested, kindly contact the ISAM Conference organizers here

 

 

Approved Sponsors 

 

 

 

 

Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New investigational drug products are based on our proprietary FluidCrystal® drug delivery technologies with the purpose to deliver improved quality of life, treatment outcomes and resource utilization. For more information:

www.camurus.com 

www.Buvidal.com 

 

 

 

MagVenture is a market-leading manufacturer of non-invasive Transcranial Magnetic Stimulation (TMS) systems. Privately-owned and headquartered in Denmark, MagVenture has been pioneering cutting-edge TMS solutions for more than 30 years. MagVenture’s TMS systems are used for a wide range of applications in both research and treatment in the fields of psychiatry, neurophysiology, neurology, cognitive neuroscience, and rehabilitation.

Dedicated to developing advanced TMS technology, MagVenture’s mission is to be the most dynamic and innovative supplier of TMS solutions worldwide and to make a difference in people’s lives through TMS research and treatment. MagVenture’s products are available on the global market through direct sales subsidiaries in the USA, Germany, the UK, and Brazil, and through a global network of distributors.  

 

https://www.magventure.com